Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Pediatr Nephrol. 2016 Oct 26;32(3):377–381. doi: 10.1007/s00467-016-3540-0

Table 1.

Suggested Use of NGAL in Urinary Tract Infection, Pyelonephritis, Vesicoureteral Reflux (VUR), and Hydronephrosis

Condition Type of NGAL Recommended Use
Urinary Tract Infection Urine Single measurement in acute setting to identify gram negative urinary tract infection
Pyelonephritis Plasma or Plasma / Urine combination Single measurement in acute setting to differentiate upper tract infection and systemic inflammation from lower tract infection
VUR / Prediction of Scarring Urine Longitudinal measurement to monitor for development or worsening of scarring
Hydronephrosis Urine or Plasma Longitudinal measurement to monitor for development of renal damage, or single measurement when concern for acute obstruction